AU Stock MarketDetailed Quotes

MDCDA Medlab Clinical Ltd

Watchlist

0.000
0.0000.00%

20min DelayNot Open Sep 9 10:00 AET

0Market Cap0.00P/E (Static)

Medlab Clinical Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Total revenue

54.45%4.4M

2.85M

Operating revenue

54.45%4.4M

--2.85M

Cost of revenue

4.81%2.94M

2.8M

Gross profit

3,254.06%1.46M

43.52K

Operating expense

7.05%17.45M

16.3M

Selling and administrative expenses

3.21%8.89M

--8.61M

-Selling and marketing expense

-55.97%770.69K

--1.75M

-General and administrative expense

18.30%8.12M

--6.86M

Depreciation amortization depletion

-9.11%873.5K

--961K

-Depreciation and amortization

-9.11%873.5K

--961K

Other operating expenses

14.27%7.68M

--6.72M

Operating profit

1.65%-15.99M

-16.26M

Net non-operating interest income (expenses)

6.01%-113.87K

-121.15K

Non-operating interest income

-66.91%25.2K

--76.14K

Non-operating interest expense

-70.96%57.28K

--197.29K

Total other finance cost

--81.78K

----

Other net income (expenses)

28.06%3.7M

2.89M

Other non-operating income (expenses)

28.06%3.7M

--2.89M

Income before tax

8.05%-12.4M

-13.49M

Income tax

0

0

Earnings from equity interest net of tax

Net income

8.05%-12.4M

-13.49M

Net income continuous operations

8.05%-12.4M

---13.49M

Noncontrolling interests

11.04%-79.12K

-88.94K

Net income attributable to the company

8.03%-12.32M

-13.4M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

8.03%-12.32M

-13.4M

Diluted earnings per share

29.63%-6.27

-8.91

Basic earnings per share

29.63%-6.27

-8.91

Dividend per share

Accounting Standards

US-GAAP

US-GAAP

	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Total revenue	54.45%4.4M	2.85M
Operating revenue	54.45%4.4M	--2.85M
Cost of revenue	4.81%2.94M	2.8M
Gross profit	3,254.06%1.46M	43.52K
Operating expense	7.05%17.45M	16.3M
Selling and administrative expenses	3.21%8.89M	--8.61M
-Selling and marketing expense	-55.97%770.69K	--1.75M
-General and administrative expense	18.30%8.12M	--6.86M
Depreciation amortization depletion	-9.11%873.5K	--961K
-Depreciation and amortization	-9.11%873.5K	--961K
Other operating expenses	14.27%7.68M	--6.72M
Operating profit	1.65%-15.99M	-16.26M
Net non-operating interest income (expenses)	6.01%-113.87K	-121.15K
Non-operating interest income	-66.91%25.2K	--76.14K
Non-operating interest expense	-70.96%57.28K	--197.29K
Total other finance cost	--81.78K	----
Other net income (expenses)	28.06%3.7M	2.89M
Other non-operating income (expenses)	28.06%3.7M	--2.89M
Income before tax	8.05%-12.4M	-13.49M
Income tax	0	0
Earnings from equity interest net of tax
Net income	8.05%-12.4M	-13.49M
Net income continuous operations	8.05%-12.4M	---13.49M
Noncontrolling interests	11.04%-79.12K	-88.94K
Net income attributable to the company	8.03%-12.32M	-13.4M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	8.03%-12.32M	-13.4M
Diluted earnings per share	29.63%-6.27	-8.91
Basic earnings per share	29.63%-6.27	-8.91
Dividend per share
Accounting Standards	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall